Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock
Company Appoints D. Keith Grossman to Board of Directors The [...]
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development [...]
Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical [...]
Innovative Medical Equipment, LLC Highlights Published VA Clinical Study on Thermal Therapy and Pain Treatment Utilization
The study, published in The March 2026 edition of Federal [...]
Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity Published in JAMA Neurology
The Journal of the American Medical Association (JAMA Neurology) publication [...]
Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Results
Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) [...]
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]
Medicus Pharma reports positive Phase 2 SKNJCT-003 Topline Data observing 73% Clinical Clearance and 40% Histological Clearance at day 57
The company is expected to finalize the Clinical Study Report [...]
Gut Bacteria and Diet Can Reprogram Fat to Burn More Energy According to A Recent Study
Findings published in Nature uncover a microbiome-driven pathway that turns [...]
Blue Earth Diagnostics Reports Favorable Head‑to‑Head Study Results Comparing POSLUMA® (Flotufolastat F 18) and Piflufolastat F 18 for Assessing Urinary Bladder Radioactivity in Men with Biochemical Recurrent Prostate Cancer
“This rigorous head-to-head study provides high-quality evidence that POSLUMA has [...]